abagovomab 33
abciximab 28
abituzumab 16
abrilumab 15
actoxumab 20
adalimumab 9
aducanumab 11
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 38
alirocumab 14
amatuximab 40
andecaliximab 25
anifrolumab 22
anrukinzumab 14
aprutumab 15
aprutumab_ixadotin 15
arcitumomab 14
ascrinvacumab 14
atezolizumab 10
atinumab 17
avelumab 13
basiliximab 33
bavituximab 28
begelomab 22
benralizumab 19
bevacizumab_beta 16
bezlotoxumab 20
bimagrumab 16
bleselumab 26
blinatumomab 32
blosozumab 29
bococizumab 24
brazikumab 14
brentuximab_vedotin 26
briakinumab 14
brodalumab 12
brolucizumab 20
brontictuzumab 26
burosumab 25
cabiralizumab 26
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 33
carlumab 18
carotuximab 8
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 22
cetiximab 32
citatuzumab_bogatox 25
cixutumumab 33
clivatuzumab_tetraxetan 21
codrituzumab 23
conatumumab 20
concizumab 14
crenezumab 15
crizanlizumab 22
crotedumab 21
dacetuzumab 23
daclizumab 18
dalotuzumab 30
dapirolizumab_pegol 25
daratumumab 13
dectrekumab 9
demcizumab 26
denosumab 7
depatuxizumab 25
depatuxizumab_mafodotin 25
dezamizumab 21
dinutuximab 34
diridavumab 21
domagrozumab 11
drozitumab 17
duligotuzumab 20
durvalumab 13
dusigitumab 27
efalizumab 33
efungumab 18
eldelumab 17
elezanumab 20
elgemtumab 4
elotuzumab 15
emactuzumab 23
emapalumab 18
emibetuzumab 23
enavatuzumab 24
enfortumab_vedotin 10
enoblituzumab 17
enokizumab 28
enoticumab 21
ensituximab 31
eptinezumab 10
erenumab 25
etaracizumab 12
etrolizumab 22
evinacumab 17
evolocumab 17
farletuzumab 0
fasinumab 24
fezakinumab 22
fibatuzumab 15
ficlatuzumab 29
firivumab 27
flanvotumab 19
fletikumab 36
foralumab 15
foravirumab 14
fremanezumab 24
fresolimumab 15
fulranumab 15
futuximab 16
galcanezumab 15
ganitumab 25
gantenerumab 14
gemetuzumab 30
gemtuzumab2 29
gemtuzumab 12
gevokizumab 24
girentuximab 28
glembatumumab 25
glembatumumab_vedotin 25
guselkumab 20
ibalizumab 25
ibritumomab 32
icrucumab 15
idarucizumab 31
ifabotuzumab 15
imalumab 11
imgatuzumab 24
inclacumab 16
indatuximab_ravtansin 30
indusatumab 21
inebilizumab 22
intetumumab 13
iodine_girentuximab 22
ipilimumab 4
iratumumab 23
isatuximab 29
itolizumab 20
ixekizumab 24
labetuzumab_govitecan 24
lambrolizumab 27
lampalizumab 26
lanadelumab 19
landogrozumab 16
laprituximab 25
lebrikizumab 30
lendalizumab 31
lenzilumab 23
lifastuzumab_vedotin 16
ligelizumab 24
lilotomab 31
lirilumab 26
lodelcizumab 23
lokivetmab 12
lorvotuzumab_mertansin 15
lucatumumab 28
lumretuzumab 20
lupartumab 13
lutikizumab 12
margetuximab 31
milatuzumab 18
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 37
mogamulizumab 18
monalizumab 23
motavizumab 31
moxetumomab_pasudotox 14
namilumab 20
naratuximab 34
naratuximab_emtansin 34
narnatumab 16
navicixizumab2 27
navicixizumab 26
navivumab 15
necitumumab 21
nemolizumab 29
nesvacumab 14
nivolumab 17
obiltoxaximab 17
obinutuzumab 28
ocaratuzumab 22
ofatumumab 14
olaratumab 21
olokizumab 21
omalizumab 19
onartuzumab 22
ontuxizumab 19
opicinumab 13
orticumab 9
otelixizumab 25
oxelumab 8
ozanezumab 21
pamrevlumab 7
panobacumab 19
parsatuzumab 29
pasotuxizumab 18
pateclizumab 17
patritumab 29
pembrolizumab 27
perakizumab 20
pidilizumab 14
pinatuzumab_vedotin 17
plozalizumab 13
pogalizumab 28
polatuzumab_vedotin 19
ponezumab 29
prezalumab 14
pritoxaximab 32
quilizumab 16
racotumomab 22
radretumab 11
ralpancizumab 28
ramucirumab 9
ranevetmab 29
ranibizumab 13
refanezumab 18
remtolumab 10
rilotumumab 26
rinucumab 16
risankizumab 31
rituximab 20
rivabazumab 23
robatumumab 19
roledumab 17
romosozumab 21
rontalizumab 26
rosmantuzumab 17
rozanolixizumab 18
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 26
sapelizumab 19
sarilumab 9
secukinumab 19
seribantumab 16
setoxaximab 36
sifalimumab 15
siltuximab 12
simtuzumab 30
sirukumab 9
solanezumab 22
solitomab 22
stamulumab 22
suptavumab 24
suvizumab 20
tabalumab 15
tadocizumab 20
tamtuvetmab 31
tanezumab 26
tarextumab 9
tavolixizumab 14
telisotuzumab 28
teplizumab 17
tesidolumab 27
tezepelumab 29
tigatuzumab 13
tildrakizumab 20
timolumab 12
tisotumab 9
tosatoxumab 28
tositumomab 29
tralokinumab 31
trastuzumab 26
tregalizumab 19
trevogrumab 8
ublituximab 29
urelumab 24
ustekinumab 22
utomilumab 22
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 18
vantictumab 25
vanucizumab2 16
vanucizumab 29
varlilumab 18
vatelizumab 24
vedolizumab 18
veltuzumab 24
vesencumab 8
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 30
xentuzumab 17
zatuximab 37
